The hypoxic milieu recruits myeloid-derived suppressor cells (MDSCs) to the primary tumor site by activating the transcription of chemokine ligand in cancer cells [40] and promoting ectonucleoside triphosphate diphosphohydrolase 2 (ENTPD2/CD39L1) [41]. The gene discussed is ENTPD2; the disease is neoplasm.